Other languages NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Market Closed - NSE India S.E. Other stock markets 07:43:53 2024-05-13 am EDT			5-day change	1st Jan Change
974.5 ^INR	+0.05%		-4.09%	+20.11%

May. 08	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT
May. 08	AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	May. 08
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	May. 08
Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	Apr. 09
NATCO Pharma Limited Announces Board Appointments	Mar. 27
INDIA STOCKS-Indian shares erase early gains, weighed down by IT stocks	Feb. 18
NATCO Pharma Limited Revises Earnings Guidance for the Fiscal Year 2024	Feb. 15
Corporate Action-Board Approves Third Interim Dividend for the Financial Year 2023-24, Payable on 4 March 2024	Feb. 14
NATCO Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14
Floods Disrupt Operations of Natco Pharma's Plant in Tamil Nadu, India	Dec. 07
Natco Pharma's Consolidated Profit Soars in Fiscal Q2, Declares Second Interim Dividend	Nov. 14
NATCO Pharma Limited Declares Second Interim Dividend for the Financial Year 2023-24, Payable on 1 December, 2023	Nov. 14
NATCO Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14
US FDA Clears Natco Pharma's Pharmacovigilance Department in Hyderabad, India	Nov. 02
Indian Equities End Higher for Sixth Straight Day, Buoyed by Banking, Public Sector Enterprises	23-09-08
Natco Pharma, Three Others Face Antitrust Violation Raps in US; Natco Pharma Shares Drop 3%	23-09-08
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit	23-09-06
Indian shares set to open flat on caution ahead of GDP data	23-08-30
Natco Pharma to Form UK Arm	23-08-09
NATCO Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NATCO Pharma Limited

Equities

NATCOPHARM

INE987B01026

Other languages

Filters